ClinicalTrials.gov
ClinicalTrials.gov Menu

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03027388
Recruitment Status : Not yet recruiting
First Posted : January 23, 2017
Last Update Posted : October 9, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : August 30, 2020
  Estimated Study Completion Date : August 30, 2020